Chris@CNW, Author at CannabisNewsWire

ThursdayAug 29, 2024 10:30 am

InMed Pharmaceuticals Inc.’s (NASDAQ: INM) INM-901: A Promising New Candidate for Alzheimer’s Therapy

INM-901 oral formulation shows encouraging results in preclinical studies High bioavailability of INM-901 oral formulation was shown to provide similar drug concentration levels in the brain as intraperitoneal injection Oral delivery method offers advantages such as lower treatment costs, in comparison with intravenous delivery of large molecule antibody therapies The company is conducting further research including drug metabolism studies, dose ranging studies and pharmacokinetic studies InMed Pharmaceuticals (NASDAQ: INM), a clinical stage pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates targeting the CB1/CB2 receptors, announced that its drug candidate INM-901 as an oral formulation will…

WednesdayAug 28, 2024 4:20 pm

420 with CNW — Americans’ Opinions of Marijuana’s Effects Decline Further, Poll Shows

Americans’ perceptions of cannabis’ effects have become less optimistic over the last two years; a slight majority now worry that most users (51%) and society as a whole are harmed by it. This is a significant change from 2022, when opinions were more evenly divided and more people (53%) thought marijuana had a good impact on users, while only 45% thought it had a negative one. These new insights are based on a Gallup Consumption Habits survey conducted from July 1 to July 21, 2024, which shows that a sizable portion of different demographics still have favorable opinions of marijuana.…

WednesdayAug 28, 2024 10:00 am

Study Says Cannabis Best Option for Women to Manage Endometriosis Symptoms

Endometriosis is a chronic illness that causes tissue similar to the uterine lining to grow on other organs in the body. This condition can cause severe pain in patients, particularly during periods, sexual intercourse and bowel movements. The inflammatory illness affects about 190 million girls and women of reproductive age around the globe. It has no known cure, with treatment focusing on managing its symptoms. Now, new research has found that cannabis may help women manage symptoms of endometriosis. For the new study, researchers conducted an analysis of survey responses from 912 adult patients suffering from endometriosis in Switzerland, Austria…

TuesdayAug 27, 2024 4:20 pm

420 with CNW — Ohio’s Adult-Use Cannabis Sales Exceed $11M in First Week

Ohio’s recreational marijuana market has experienced impressive growth, generating more than $11.5 million in sales in its first week. According to the state’s Commerce Department, Cannabis Control Division, the total revenue from adult-use cannabis sales reached $11,530,708 as of Aug. 10, 2024. Sales officially began on Aug. 6, eight months after Ohio voters approved recreational cannabis legalization, with 57% of voters supporting the ballot measure. The average cost of an ounce of flower was $266. The data shows that 1,285 pounds of cannabis plant material and 173,043 units of processed products were sold. Ohio’s medical marijuana market is also thriving,…

TuesdayAug 27, 2024 10:00 am

Stores in Southwest Virginia Openly Sell Marijuana

In Virginia, medical and recreational marijuana is legal, although retail sales and recreational marijuana dispensaries haven’t yet been launched following delays with the approval of a re-enactment clause. However, residents in the southwest region of the state can still access the drug easily, with many stores openly selling the substance. This is despite some of these businesses being raided by law enforcement last year. The sale of marijuana in this part of the country is surprising, especially since the stores are in the most conservative parts of Virginia. There’s at least one marijuana store in Tazewell County and another in…

MondayAug 26, 2024 4:20 pm

420 with CNW — California Senators Pass Bill Authorizing Cannabis Growers to Sell at Farmers’ Markets

California Senate lawmakers have advanced a bill that would grant small cannabis cultivators a new license to sell directly to consumers at state-run farmers’ markets and other transient events. Additionally, the bill would allow adults to use cannabis at events that have been approved. The bill does not, however, imply that small marijuana farmers can openly sell their goods at farmers’ markets alongside other merchants. Cannabis sales in approved locations would require certain regulatory permits from state and local authorities. The assembly initially approved the bill in May, where it received overwhelming support before heading to the senate. The bill…

MondayAug 26, 2024 12:00 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Validates Technology’s Superiority, Moving Closer to a Share in the Global Diabetes Treatment Market

Lexaria, a global innovator in drug delivery platforms, just reported positive results from its applied research program conducted in collaboration with the National Research Council of Canada (“NRC”) The study’s objective was to examine the molecular properties of semaglutide, processed with its patented DehydraTECH(TM) technology, comparing it to Rybelsus(R), the commercially available alternative Lexaria’s DehydraTECH demonstrated that semaglutide can be efficiently released in a simulated gastric fluid environment, without the use of salcaprozate sodium (“SNAC”) ingredient chemistry This milestone moves the company closer to the diabetes treatment market, projected to hit $153.98 billion in value by 2032 Lexaria Bioscience (NASDAQ:…

MondayAug 26, 2024 9:00 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Promising Long-Term Results for Alzheimer’s Drug INM-901

A long-term preclinical study of Alzheimer's Disease (“AD”) drug candidate INM-901 included four groups: untreated disease-free, INM-901-treated disease-free, placebo-treated Alzheimer's Disease, and INM-901-treated Alzheimer's Disease at two dosing levels The results showed that INM-901-treated AD groups displayed behavior trends similar to the untreated disease-free group, with a clear dose response observed in most assessments The drug has also shown a reduction in neuroinflammation and enhancement of neuronal function, with molecular data supporting behavioral study observations InMed Pharmaceuticals (NASDAQ: INM), a biopharmaceutical company focused on developing proprietary small molecule drug candidates for diseases with high unmet needs, has announced promising outcomes…

FridayAug 23, 2024 4:20 pm

420 with CNW — Federal Researchers Look into Game-Changing Way to Detect Recent Cannabis Use in Breath

Federal authorities are adopting a new strategy to assess recent marijuana use by revising protocols for analyzing THC breath samples. The initiative is part of continuing efforts to improve the accuracy and reliability of cannabis impairment field testing, particularly in drivers. Researchers from the University of Colorado and the National Institute of Standards and Technology (NIST) propose that using two breath tests within an hour could be more effective than relying on a single test. They aim to determine if this method could be developed into a practical field test. One of the biggest obstacles to marijuana legislation has been…

FridayAug 23, 2024 10:00 am

Ongoing Battle in California Symbolizes the Longstanding Struggle Between Marijuana and Hemp

Governor Gavin Newsom of California is working toward regulating intoxicating products derived from hemp, via the state Department of Cannabis Control. The governor is actively looking into ways to increase enforcement, close loopholes and prevent underage kids from having access to unsafe marijuana and hemp products. In a recent statement, Gov. Newsom argued that these products needed to be subjected to safety and health regulations, just as marijuana products are. This sentiment is echoed by most observers, who agree that at some point, marijuana and hemp will be subject to the same rules. What those rules will be and when…